Affiliation:
1. B.K. Mody Government Pharmacy College, Rajkot, Gujrat, India.
Abstract
RP- UPLC method was developed and validated for the simultaneous determination of Rabeprazole sodium and Mosapride citrate in tablet dosage form. The separation was achieved on a BEH C18 (50mm × 2.1mm× 1.7µm) column using mobile phase of Ammonium acetate buffer: Acetonitrile (60:40% v/v). The flow rate was 0.4 ml/min and detection was carried out at 270nm and column oven 35ºC. Rabeprazole sodium and Mosapride citrate was subjected to stress condition including Acidic, Alkaline, Oxidation, Photolysis and Thermal degradation. This method was validated as per ICH (Q2R1) guideline.
Subject
Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference12 articles.
1. Desai CA, Samant BD.A Review of Rabeprazole. Journal of Postgraduate Medicine. 2002; 48-50.
2. Drug Profile and Information of Mosapride citrate, September 2019,https://pubchem.ncbi.nlm.nih.gov/compound/Mosapride-citrate
3. Drug Combination, “Rabeprazole sodium and Mosapride citrate”, September 2019, https://www.1mg.com/drugs/rabeflux-20mg-15mg-tablet-305046
4. Blessy M, Patel RD, Prajapati PN and Agrawal YK. Development of forced degradation and stability indicating studies of drugs – A review. Journal of Pharmaceutical Analysis. 2013; 4:159- 165.
5. ICH – Harmonized Tripartite Guideline, “Stability testing of New drug substance and products Q1A (R2)”, International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2003.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献